TrialJAMA neurology2025

Optimal Antithrombotics for Ischemic Stroke and Concurrent Atrial Fibrillation and Atherosclerosis: A Randomized Clinical Trial.

Shuhei Okazaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.